-
1
-
-
0022002257
-
Evidence for differential localization of noradrenaline and neuropeptide Y (NPY) in neuronal storage vesicles isolated from rat vas deferens
-
Fried G, Terenius L, Hökfelt T, Goldstein M. Evidence for differential localization of noradrenaline and neuropeptide Y (NPY) in neuronal storage vesicles isolated from rat vas deferens. J Neurosci 1985; 5: 450-5.
-
(1985)
J Neurosci
, vol.5
, pp. 450-455
-
-
Fried, G.1
Terenius, L.2
Hökfelt, T.3
Goldstein, M.4
-
3
-
-
0023104312
-
Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man
-
Pernow J, Lundberg JM, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 1987; 40: 47-54.
-
(1987)
Life Sci
, vol.40
, pp. 47-54
-
-
Pernow, J.1
Lundberg, J.M.2
Kaijser, L.3
-
5
-
-
0021135158
-
Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels
-
Edvinsson L, Ekblad E, Håkanson R, Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984; 83: 519-25.
-
(1984)
Br J Pharmacol
, vol.83
, pp. 519-525
-
-
Edvinsson, L.1
Ekblad, E.2
Håkanson, R.3
Wahlestedt, C.4
-
6
-
-
0024515445
-
Co-existence of neuropeptides and differential inhibition of vasodilator responses by neuropeptide Y in guinea pig uterine arteries
-
Fallgren B, Ekblad E, Edvinsson L. Co-existence of neuropeptides and differential inhibition of vasodilator responses by neuropeptide Y in guinea pig uterine arteries. Neurosci Lett 1989; 100: 71-6.
-
(1989)
Neurosci Lett
, vol.100
, pp. 71-76
-
-
Fallgren, B.1
Ekblad, E.2
Edvinsson, L.3
-
7
-
-
0027512327
-
Neuropeptide Y-related peptides and their receptors - Are the receptors potential therapeutic drug targets?
-
Wahlestedt C, Reis DJ, Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 1993; 32: 309-52.
-
(1993)
Annu Rev Pharmacol Toxicol
, vol.32
, pp. 309-352
-
-
Wahlestedt, C.1
Reis, D.J.2
-
8
-
-
0027456350
-
Genomic organisation, localisation and allelic differences in the gene for the human neuropeptide Y Y1 receptor
-
Herzog H, Baumgartner M, Vivero C, Selbie LA, Bernhard A, Shine J. Genomic organisation, localisation and allelic differences in the gene for the human neuropeptide Y Y1 receptor. J Biol Chem 1993; 268: 7703-7.
-
(1993)
J Biol Chem
, vol.268
, pp. 7703-7707
-
-
Herzog, H.1
Baumgartner, M.2
Vivero, C.3
Selbie, L.A.4
Bernhard, A.5
Shine, J.6
-
10
-
-
0022588106
-
Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides
-
Wahlestedt C, Yanaihara N, Håkanson R. Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Reg Pept 1986; 13: 307-18.
-
(1986)
Reg Pept
, vol.13
, pp. 307-318
-
-
Wahlestedt, C.1
Yanaihara, N.2
Håkanson, R.3
-
11
-
-
0029100680
-
Cloning and functional expression of a cDNA encoding a human type 2 Neuropeptide Y receptor
-
Rose PM, Fernandes P, Lynch JS, et al. Cloning and functional expression of a cDNA encoding a human type 2 Neuropeptide Y receptor. J Biol Chem 1995; 270: 22661-4.
-
(1995)
J Biol Chem
, vol.270
, pp. 22661-22664
-
-
Rose, P.M.1
Fernandes, P.2
Lynch, J.S.3
-
13
-
-
0026545954
-
Characterization of vascular neuropeptide Y receptors
-
Grundemar L, Mörner S, Högestätt E, Wahlestedt C, Håkanson R. Characterization of vascular neuropeptide Y receptors. Br Pharmacol 1992; 105: 45-50.
-
(1992)
Br Pharmacol
, vol.105
, pp. 45-50
-
-
Grundemar, L.1
Mörner, S.2
Högestätt, E.3
Wahlestedt, C.4
Håkanson, R.5
-
14
-
-
0026050807
-
Evidence for two neuropeptide Y receptors mediating vasoconstriction
-
Modin A, Pernow J, Lundberg JM. Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol 1991; 203: 165-71.
-
(1991)
Eur J Pharmacol
, vol.203
, pp. 165-171
-
-
Modin, A.1
Pernow, J.2
Lundberg, J.M.3
-
15
-
-
0028357934
-
Neuropeptide Y in sympathetic co-transmission: Recent advances in the search for neuropeptide Y antagonists
-
Edvinsson L, Erlinge D, Sun XY, Hedner T. Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists. Pharmacol Toxicol 1994; 74: 193-201.
-
(1994)
Pharmacol Toxicol
, vol.74
, pp. 193-201
-
-
Edvinsson, L.1
Erlinge, D.2
Sun, X.Y.3
Hedner, T.4
-
18
-
-
0025325556
-
Neuropeptide Y in cerebrovascular function: Comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in guinea pig basilar arteries
-
Fallgren B, Arlock P, Jansen I, Edvinsson L. Neuropeptide Y in cerebrovascular function: comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in guinea pig basilar arteries. Neurosci Lett 1990; 114: 117-22.
-
(1990)
Neurosci Lett
, vol.114
, pp. 117-122
-
-
Fallgren, B.1
Arlock, P.2
Jansen, I.3
Edvinsson, L.4
-
20
-
-
0028878991
-
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP3226
-
Wieland HA, Willim KD, Entzeroth M, et al. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP3226. J Pharmacol Exp Ther 1995; 275: 143-9.
-
(1995)
J Pharmacol Exp Ther
, vol.275
, pp. 143-149
-
-
Wieland, H.A.1
Willim, K.D.2
Entzeroth, M.3
-
21
-
-
0028828971
-
Pharmacological characterization of the selective nonpeptide neuropeptid Y Y1 receptor antagonist BIBP3226
-
Doods HN, Wienen W, Entzeroth M, et al. Pharmacological characterization of the selective nonpeptide neuropeptid Y Y1 receptor antagonist BIBP3226. J Pharmacol Exp Ther 1995; 275: 136-42.
-
(1995)
J Pharmacol Exp Ther
, vol.275
, pp. 136-142
-
-
Doods, H.N.1
Wienen, W.2
Entzeroth, M.3
-
23
-
-
0001931302
-
1 receptors mediating vasoconstriction in human cerebral arteries
-
1 receptors mediating vasoconstriction in human cerebral arteries. Neurosci Lett 1996; 203: 1-4.
-
(1996)
Neurosci Lett
, vol.203
, pp. 1-4
-
-
Nilsson, T.1
Cantera, L.2
Edvinsson, L.3
-
24
-
-
0026548492
-
Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate)
-
Adamsson M, Fallgren B, Edvinsson L. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Br J Pharmacol 1992; 105: 93-6.
-
(1992)
Br J Pharmacol
, vol.105
, pp. 93-96
-
-
Adamsson, M.1
Fallgren, B.2
Edvinsson, L.3
-
25
-
-
0023192323
-
Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: Coexistence with vasoactive intestinal peptide and choline acetyltransferase
-
Leblanc GG, Trimmer BA, Landis SC. Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: coexistence with vasoactive intestinal peptide and choline acetyltransferase. Proc Natl Acad Sci USA 1987; 84: 3511-5.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 3511-3515
-
-
Leblanc, G.G.1
Trimmer, B.A.2
Landis, S.C.3
-
26
-
-
0026705648
-
Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: Blockade by D-myo-inositol-1,2,6-triphosfate
-
Edvinsson L, Adamsson M. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: Blockade by D-myo-inositol-1,2,6-triphosfate. J Cardiovasc Pharmacol 1992; 20: 466-72.
-
(1992)
J Cardiovasc Pharmacol
, vol.20
, pp. 466-472
-
-
Edvinsson, L.1
Adamsson, M.2
|